Don't Ignore The Insider Selling In U.S. Physical Therapy
Don't Ignore The Insider Selling In U.S. Physical Therapy
Anyone interested in U.S. Physical Therapy, Inc. (NYSE:USPH) should probably be aware that the President & COO, Eric Williams, recently divested US$192k worth of shares in the company, at an average price of US$95.84 each. The eyebrow raising move amounted to a reduction of 12% in their holding.
任何對美國物理治療公司(紐交所:USPH)感興趣的人,應該知道總裁兼首席運營官埃裏克·威廉姆斯最近以每股平均95.84美元的價格出售了19.2萬美元的公司股票。這一引人關注的舉動導致其持股減少了12%。
The Last 12 Months Of Insider Transactions At U.S. Physical Therapy
美國物理治療過去12個月的內部交易
In the last twelve months, the biggest single sale by an insider was when the Chairman & CEO, Christopher Reading, sold US$291k worth of shares at a price of US$100 per share. So we know that an insider sold shares at around the present share price of US$91.87. We generally don't like to see insider selling, but the lower the sale price, the more it concerns us. In this case, the big sale took place at around the current price, so it's not too bad (but it's still not a positive).
在過去的十二個月中,內部人士最大的一筆銷售是董事長兼首席執行官克里斯托弗·瑞丁以每股100美元的價格出售了29.1萬美元的股票。因此,我們知道一個內部人士在當前每股91.87美元的價格出售了股票。我們通常不喜歡看到內部人士賣出股票,但賣出價格越低,越讓我們擔憂。在這種情況下,這筆大規模的出售發生在當前價格附近,所以情況還算不錯(但這仍然不是一個積極的信號)。
Over the last year we saw more insider selling of U.S. Physical Therapy shares, than buying. You can see the insider transactions (by companies and individuals) over the last year depicted in the chart below. If you click on the chart, you can see all the individual transactions, including the share price, individual, and the date!
在過去一年中,我們看到美國物理治療的內部人士出售股票的情況比購買的情況要多。您可以在下面的圖表中看到過去一年內部交易(由公司和個人)描繪的情況。如果您單擊圖表,您可以看到所有單獨的交易,包括股價、個人和日期!
For those who like to find hidden gems this free list of small cap companies with recent insider purchasing, could be just the ticket.
對於那些喜歡發現潛力股票的人,可以免費查看最新內部交易股票的小盤公司名單,這可能正是您要找的機會。
Does U.S. Physical Therapy Boast High Insider Ownership?
美國物理治療公司是否擁有高比例的內部股權?
Looking at the total insider shareholdings in a company can help to inform your view of whether they are well aligned with common shareholders. We usually like to see fairly high levels of insider ownership. It appears that U.S. Physical Therapy insiders own 1.6% of the company, worth about US$23m. We've certainly seen higher levels of insider ownership elsewhere, but these holdings are enough to suggest alignment between insiders and the other shareholders.
查看公司的內部持股總量可以幫助您了解他們與普通股東的一致性。我們通常希望看到相對較高的內部持股比例。美國物理治療公司的內部人士似乎擁有1.6%的公司股份,價值約2300萬美金。我們確實在其他地方看到過更高的內部持股比例,但這些持股足以表明內部人士與其他股東之間的一致性。
So What Does This Data Suggest About U.S. Physical Therapy Insiders?
那麼這些數據對美國物理治療公司的內部人士有什麼啓示?
The stark truth for U.S. Physical Therapy is that there has been more insider selling than insider buying in the last three months. Despite some insider buying, the longer term picture doesn't make us feel much more positive. Insiders own shares, but we're still pretty cautious, given the history of sales. We'd practice some caution before buying! While it's good to be aware of what's going on with the insider's ownership and transactions, we make sure to also consider what risks are facing a stock before making any investment decision. To assist with this, we've discovered 4 warning signs that you should run your eye over to get a better picture of U.S. Physical Therapy.
對於美國物理治療公司來說最嚴峻的事實是,過去三個月內部賣出的股份多於買入的股份。儘管有一些內部買入,但從長遠來看,這並沒有讓我們更加樂觀。內部人士擁有股份,但考慮到銷售的歷史,我們仍然相當謹慎。在買入之前我們會保持一些謹慎!雖然了解內部人士的持股和交易情況是好的,但我們還需要考慮影響股票的風險,才能做出任何投資決策。爲此,我們發現了4個警示信號,您應該關注,以更好地了解美國物理治療公司。
Of course U.S. Physical Therapy may not be the best stock to buy. So you may wish to see this free collection of high quality companies.
當然,美國物理治療公司可能不是最好的買入股票。所以您可能想看看這份免費的高質量公司集合。
For the purposes of this article, insiders are those individuals who report their transactions to the relevant regulatory body. We currently account for open market transactions and private dispositions of direct interests only, but not derivative transactions or indirect interests.
對於本文而言,內部人是指向相關監管機構報告其交易的個人。我們目前僅考慮公開市場交易和直接利益的私人處置,但不包括衍生交易或間接利益。
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
對這篇文章有反饋嗎?對內容感到擔憂嗎?請直接與我們聯繫。或者,發送電子郵件至editorial-team @ simplywallst.com。
Simply Wall St的這篇文章是一般性質的。我們僅基於歷史數據和分析師預測提供評論,使用公正的方法,我們的文章並非意在提供財務建議。這並不構成買入或賣出任何股票的建議,並且不考慮您的目標或財務狀況。我們旨在爲您帶來基於基礎數據驅動的長期聚焦分析。請注意,我們的分析可能未考慮最新的價格敏感公司公告或定性材料。Simply Wall St對提及的任何股票都沒有持倉。
譯文內容由第三人軟體翻譯。